Blue Trust Inc’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.3K Hold
5,000
﹤0.01% 1668
2026
Q1
$19.8K Hold
5,000
﹤0.01% 1649
2025
Q4
$33.9K Hold
5,000
﹤0.01% 1490
2025
Q3
$34.9K Hold
5,000
﹤0.01% 1522
2025
Q2
$30.6K Hold
5,000
﹤0.01% 1575
2025
Q1
$38K Hold
5,000
﹤0.01% 1482
2024
Q4
$48.1K Hold
5,000
﹤0.01% 1317
2024
Q3
$34.6K Buy
+5,000
New +$33.1K ﹤0.01% 1718
2024
Q2
Sell
-5,000
Closed -$38.5K 2704
2024
Q1
$38.5K Hold
5,000
﹤0.01% 1002
2023
Q4
$36K Hold
5,000
﹤0.01% 1056
2023
Q3
$33K Hold
5,000
﹤0.01% 996
2023
Q2
$17K Hold
5,000
﹤0.01% 1109
2023
Q1
$14K Hold
5,000
﹤0.01% 1502
2022
Q4
$14K Hold
5,000
﹤0.01% 1422
2022
Q3
$17K Buy
+5,000
New +$17.8K ﹤0.01% 1150

Other funds holding MDXG

Blue Trust Inc's MDXG Position: Q2 2026 in Review

Blue Trust Inc held its MiMedx Group (MDXG) position steady in Q2 2026 at 5,000 shares worth $19.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1668.

Blue Trust Inc first reported a position in MDXG in Q3 2022 and has held it in 15 quarters since. The position peaked at $48.1K in Q4 2024. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Blue Trust Inc held 5,000 shares of MiMedx Group worth $19.3K as of Q2 2026.
  • Blue Trust Inc left its MiMedx Group share count unchanged in Q2 2026.
  • MiMedx Group made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1668 holding.
  • Blue Trust Inc first reported a position in MiMedx Group in Q3 2022 and has held it in 15 quarters since.
  • Blue Trust Inc's MiMedx Group position peaked at $48.1K in Q4 2024.
  • 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.